Mr. Chris Buyse is a Managing Partner at Fund+, a Co-Managing Director at Sofia BVBA and an Independent Director at Inventiva SA.
He is on the Board of Directors at CoBioRes NV, Celyad Oncology SA, Bio-Incubator Leuven, Creabuild NV, EyeD Pharma SA, Fondation Francqui, Intrexon ActoBiotics NV, iTeos Therapeutics SA, Keyware Technologies NV, Life Sciences Research Partners VZW, Patcobel NV, Pienter-Jan BVBA, Pinnacle Investments NV, Inventiva SA and Bioxodes SA. Mr. Buyse was previously employed as a CFO, Executive Director & Head-Investor Relations by ThromboGenics NV, an Independent Non-Executive Director by Bone Therapeutics SA, a Chief Financial Officer by CropDesign NV, an Independent Director by Keyware Technologies NV, a Finance Director by MCI BeLux, a Group Controller by smartphoto group NV, a Controller by Suez Lyonnaise des Eaux Finance SA, a Group Controller by Unilever NV, and a Finance Director by WorldCom, Inc. /Old/.
He also served on the board at Ogeda SA, Orgenesis, Inc., Amakem NV, Immo David NV, MaSTherCell SA, PROMETHERA Biosciences SA, Q-Biologicals NV and TheraSolve NV.
He received his graduate degree from the University of Antwerp and an MBA from Vlerick Leuven Gent Management School.